Holen Sie sich die Stockscreener-App
2.1419
0.00%
0.0019
Schlusskurs vom Vortag:
$2.14
Offen:
$2.14
24-Stunden-Volumen:
2,796
Relative Volume:
0.07
Marktkapitalisierung:
$25.12M
Einnahmen:
$3.35M
Nettoeinkommen (Verlust:
$86,000
KGV:
139.08
EPS:
0.0154
Netto-Cashflow:
$2.67M
1W Leistung:
-5.31%
1M Leistung:
+3.38%
6M Leistung:
-6.96%
1J Leistung:
+98.15%
1-Tages-Spanne:
$2.12
$2.205
1-Wochen-Bereich:
$2.12
$2.3056
52-Wochen-Spanne:
$0.99
$2.95
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.17 | 24.77M | 3.35M | 86,000 | 2.67M | 0.0154 |
TAK
Takeda Pharmaceutical Co Adr
|
18.25 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.80 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.18 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.63 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.31 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TXMD Q3 2023 Earnings: EPS Misses by 154.9% as Revenue Remains at ZeroEBITDA Margin Trends - vinanet.vn
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeLong Setup Ideas - vinanet.vn
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
THERAPEUTICSMD STOCK : BIG PRICE RECOVERY | TXMD STOCK Moon (nkL8YZ0GKj) - Mshale
TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingAnalyst Drop Coverage - vinanet.vn
TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordHigh Volume Node - vinanet.vn
TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionLiquidity Order Flow - vinanet.vn
TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseSegment Revenue Breakdown - vinanet.vn
TherapeuticsMD, Inc. Revenue Breakdown – NASDAQ:TXMD - TradingView
TherapeuticsMD(TXMD) Stock Options Chain | Quotes & News - Moomoo
TherapeuticsMD Company Profile & Introduction - Moomoo
TherapeuticsMD, Inc. Revenue Breakdown – DUS:29TA - TradingView
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
TherapeuticsMD (TXMD) Holds Steady at $2.08 as Traders Eye Key Support and ResistanceBull Flag - vinanet.vn
TherapeuticsMD Q2 2026 License Revenue Drops 8.7% Year Over Year - clinicaltrialvanguard.com
TherapeuticsMD: Q2 Earnings Snapshot - AOL.com
TherapeuticsMD Q2 Net Income From Cont Ops US - Moomoo
TherapeuticsMD Q2 EPS drops 80% to $0.01 on sales slide - scanx.trade
Is TherapeuticsMD Inc (TXMD) Positioned for Growth After Q2 Earn - GuruFocus
TherapeuticsMD Q2 Results and Strategic Alternatives Review - TipRanks
TherapeuticsMD, Inc. Q2 2026: Revenue $869K, EPS $0.01— 10-Q Summary - TradingView
TherapeuticsMD Q2 license revenue falls; continues to evaluate strategic alternatives - TradingView
TherapeuticsMD Q2 2026 License Revenue Falls to $869000 - Quiver Quantitative
TherapeuticsMD | 10-Q: Q2 2026 Earnings Report - Moomoo
TherapeuticsMD Q2 2026 Earnings: License Revenue and Net Income Decline - TradingKey
TXMD: Q2 2026 saw lower net income and license revenue, with strategic alternatives under evaluation - TradingView
TherapeuticsMD (TXMD) posts Q2 2026 update and weighs strategic alternatives - Stock Titan
TherapeuticsMD to Recognize About $365K IMVEXXY Milestone in Q3 - Stock Titan
TherapeuticsMD, Inc. (29TA.SG) stock price, news, quote and history - Yahoo Finance Australia
TXMD Q3 2023 Earnings: Wider-Than-Expected Loss of -$0.13 Weighs on SharesEarnings Per Share - vinanet.vn
Baselake group (TXMD) discloses 6.8% beneficial stake in TherapeuticsMD common stock - Stock Titan
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
TherapeuticsMD, Inc. (29TA.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
TherapeuticsMD (TXMD) Holds Steady at $2.03 as Trading Range NarrowsVolume Rate Change - dars.gov.et
TXMD Q3 2023 Earnings: Wide EPS Miss Highlights Transition ChallengesEarnings Surprise Report - vinanet.vn
TXMD|TherapeuticsMD Inc|Price:2.090|Chg%:+0.060 - TradingKey
TherapeuticsMD Inc. (TXMD) Slips Further: Key Support Levels Under PressurePCR Spike - dars.gov.et
TherapeuticsMD, Inc. Revenue Breakdown – SWB:29TA - TradingView
TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TherapeuticsMD Inc (TXMD) Cash Flow - TradingKey
TherapeuticsMD (TXMD) Holds Steady Near Key Support With Slight UptickProfitability Factor - dars.gov.et
TherapeuticsMD Inc (TXMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
TherapeuticsMD, Inc. Revenue Breakdown – MUN:29TA - TradingView
TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):